Loading...
 
Toggle Health Problems and D

UK MP talked on vaccine harms, other MPs left – transcript Mar 17, 2023


Transcript

0:00:00.0 Deputy Speaker: Mr. Andrew Bridgen
Youtube
Image
Image

0:00:04.4 Bridgen: Mr. Deputy Speaker, on the 13th of December last year, I was kindly granted an adjournment debate on the potential harms that emergency use experimental mRNA COVID-19 vaccines cause. It's fair to say that night my life changed. During that speech in the evidence data I presented to the House, which no one has effectively rebutted, I highlighted to the minister the scale of harms the experimental vaccines have caused and continue to cause. In giving that speech to an almost empty chamber on this most important of issues, quite literally life and death, two things happened to me immediately. First, I was canceled by the mainstream media despite sending a data sheet in the wake of the debate, scientifically evidencing every point that I made. Not one media organization wanted to talk about the issue of serious harms or death occurring as a result of the mRNA vaccines. Mr. Deputy Speaker, I fully expect that they will show the same level of disinterest in today's debate. It's what we've come to expect from a media more interested in navel-gazing at the pontifications of Britain's foremost football pundit, instead of the horror and tragedy of excess deaths taking place before their very eyes. Some three months on from that speech and a scattering of reports are now appearing in the mainstream media. Sadly, the number of people affected in the UK and across the world cannot be ignored or hidden indefinitely.
Image

0:01:35.0 Speaker 3: 0:01:35.0 ??.

0:01:36.0 Bridgen: I will on that point.

0:01:37.8 S3: Will he accept that there's a bit of light on the horizon? In this week alone, The Daily Express has had four full pages on this subject.

0:01:47.6 Bridgen: I thank my right honorable friend, he's a stalwart supporter for those who've been vaccine harmed, and I do hope that we can see some light at the end of the tunnel and hopefully this speech today will bring more light into the darkness. In truth, I care little about being cancelled by the media because in the wake of that speech, something far more important has happened. I was contacted by thousands of people offering their support and received many hundreds and hundreds of emails from all over the globe, recounting to me their own stories of the harms caused in the wake of their or their loved ones COVID vaccination. I've been contacted by parents in my own and surrounding constituencies thanking me for questioning why we are giving these experimental vaccinations to healthy children and young people that patently do not need them and gained no protection from them. I was contacted by far too many relatives who had lost loved ones suddenly after having the Moderna, Pfizer or AstraZeneca experimental gene therapy treatments shot into their arms. Many of them asked in their emails why this vitally important issue was not being taken more seriously by many of my honorable and right honorable colleagues.

0:03:00.8 Bridgen: That Mr. Deputy Speaker is a question for my colleagues to answer. A lot more questioned why as evidence continues to emerge almost on a daily basis, the fourth estate was so remiss in its coverage, that Mr. Deputy Speaker is a question for the lobby to answer. But everyone of of those who contacted me asked me to keep up the fight, to continue to raise awareness of vaccine harms and vaccine deaths. Mr. Deputy Speaker, that is the question I am here to answer today. Despite the media silence, there is huge, enormous and growing interest in this topic. So today I once again ask the Minister why more is not being done both in the United Kingdom and globally to investigate and publicize the clear and well documented adverse effects of COVID-19 vaccines. Vaccines, Mr. Deputy Speaker, that have made big pharma billions, but also vaccines that have resulted in completely unprecedented levels of Yellow Card reports.

0:04:05.0 Bridgen: Mr. Deputy Speaker, the government's own data in this respect is damning. It is interesting that only this week the MHRA, the Medicines and Healthcare Product Regulatory Agency have announced that they will no longer be publicly reporting the Yellow Card updates from the reported harms of these experimental treatments. Can the minister explain the reasoning behind this decision, especially given that the number of Yellow Card reports of adverse events are far higher for the experimental COVID-19 vaccine than the total Yellow Card reports of all conventional vaccines administered for the last 50 years? Mr. Deputy Speaker, if you'll grant me a little leeway, let me start by looking at data from the US state of Florida and the reported level of vaccine harms there. Prior to the COVID pandemic, there were never more than 2,500 incidents per year of harms reported to the State Surgeon General as a direct result of vaccination. In 2021 that number shot up to over 41,000 cases, a surge of more than 1600%.

0:05:12.8 Bridgen: Of course, some will understandably point out that the increase in cases was inevitable as more vaccines were being administered. The answer to that Mr. Deputy Speaker, in the state of Florida, there was a 400% increase in vaccine administration in 2021, not 1600%. Mr. Deputy Speaker, in the state of Florida and in the rest of the world, 1600 doesn't go into 400, it never has and it never will. The real world data from Florida shows the mRNA vaccines are resulting in vaccine harms disproportionate to the number of vaccines being administered when compared to all previous vaccinations. And this backs up the clear warning signal from our own Yellow Card system in the UK. Data held on the US Government National Library of Medicine was used for research by Dr. Joseph Fryman, which details the frequency of serious adverse events following vaccination with both Pfizer and Moderna mRNA vaccines.

0:06:16.6 Bridgen: For clarity, Mr. Deputy Speaker, a serious adverse event is defined as anything that results in death, is life-threatening at the time of the event, results in inpatient hospitalization or prolongation of existing hospitalization, persistent or significant disability or incapacity, a congenital anomaly or birth defect or something considered as medically important based on medical judgment. Using that definition the study confirms that there are 10.1 serious adverse events for every 10,000 Pfizer vaccinations administered. Mr. Deputy Speaker, that means that one in every 990 people vaccinated with the Pfizer booster will have a serious adverse event.
The risk with the Moderna vaccine is even greater, there are 15.1 serious adverse events for every 10,000 Moderna jabs, that means one in 662 people vaccinated with the Moderna booster will have a serious adverse event. Combining the data for Pfizer and Moderna MRA vaccines or boosters, we can see that there are an average of 1250 serious adverse events for every one million vaccine boosters administered.

0:07:36.3 Bridgen: In other words, an average of one in 800 chance of a serious adverse event every time someone is boosted. So let's move on now to the UK government data. On the 25th of January of this year the Department of Health and Social Care published data from a presentation given by the UK Health Security Agency to the JCVI, the Joint Committee on Vaccination and Immunization. The data published split the population into groups by age and further divided those age groups into those considered healthy and at risk. The numbers needed to vaccinate or the NNV, for each of these subgroups were calculated to firstly prevent a single hospitalization, and secondly, a single serious hospitalization requiring oxygen or intubation, effectively intensive care. The figures are stark Mr. Deputy Speaker, what I'm quoting from is the government's own published data. To prevent just one healthy adult aged between 50 and 59 from being hospitalized due to COVID, the government's own data states that 43,600 people had to be given an autumn booster jab.

0:08:53.4 Bridgen: With a serious adverse event rate of one in 800 that means that in the healthy 50 to 59 year old group, as a result of using the mRNA boosters, 55 people would die or be put into hospital with side effects to prevent one single case presenting of COVID preventing in hospital. The same data shows that for the healthy younger people, the number needed to be boosted to prevent a single hospital admission with COVID-19 is far higher. 92,500 booster jabs were required to be administered to prevent one hospitalization due to COVID in the healthy 40 to 49 year old group, which would simultaneously have put 116 people at probability of death or serious adverse reaction into hospital from the jab. The healthy 30 to 39 year old age group required 210,400 booster jabs to prevent a single COVID hospitalization.

0:09:53.4 Bridgen: So 263 of this group will have been into hospital or sadly died as a result of the booster side effects just to keep one COVID case out of hospital. But the data gets worse, because hospitalization doesn't necessarily mean a serious medical intervention such as intubation or oxygen. To prevent severe hospitalization from COVID-19, the numbers needed to be boosted become astronomical, I would suggest that this is the real benchmark for comparison with the risks of death or serious adverse events from the boosters themselves. So the government's own data shows that in healthy adults age 50 to 59, it was necessary to give 256,400 booster jabs to prevent just one severe hospitalization, putting 321 people into hospital with a serious side effect from the booster, which includes obviously risk of death. For 40 to 49 year olds, that number increases to 932,500 who need to be boosted to keep one COVID patient out of ITU, putting potentially 1165 people into hospital with serious harms, death or disability.

0:11:07.4 Bridgen: And for the healthy 30 to 39 year olds, no one knows the answer to the number needed to be boosted to prevent a serious hospitalization, because the government's own data says that there's never been such a case of this age group being put into intensive care due to the current variant of COVID-19. But many, indeed on average one in 800 of them of this group that's been boosted will have died or been disabled or seriously harmed by the booster itself. Let me focus now on the most vulnerable group for which the government data is available. The over 70s with comorbidities, the most vulnerable group in our society. According to the government's own data, it will be necessary to administer 800 vaccine boosters to prevent just one hospitalization for a patient over the age of 70 in this highest risk group. Mr. Deputy Speaker, that means that all the most vulnerable group in our society are doing by being boosted is swapping one risk from COVID of hospitalization for exactly the same risk from the booster itself.

0:12:12.7 Bridgen: But of course in the process big pharma is making huge profits. Mr. Deputy Speaker, we've looked at the health implications of the vaccine program. Now I want to look at some of the costs implications of the booster program in the UK. Total funding of COVID-19 vaccination program in the UK up to the end of March this year is budgeted at £8.3 billion. In February 2022, the GP online website championing general practice professionals published that GPs and community pharmacists were being paid £24 per dose for administering vaccines. That figure increased to £34 per dose at dedicated vaccine centers. These costs of course do not include the cost of the experimental vaccines themselves. For ease of calculation, I will count those at £20 per dose across the board. I'll be generous and use the lower of the two figures for administering the vaccine, giving a total cost of £44 per dose.

0:13:13.5 Bridgen: But even then, I do, we see from the government's own data using boosters, it cost over £1.9 million to prevent just one hospitalization among healthy 50 to 59 year olds. And over £11 million to prevent one serious hospitalization due to COVID-19 in this age group. The cost to the taxpayer of preventing a hospitalization of one healthy 40 to 49 year old is over £4 million using boosters, and for healthy 30 to 39 year olds, the cost of preventing just one hospitalization is over £9 million Mr. Deputy Speaker. Of course to prevent serious hospitalization in all these groups the cost is far, far higher. It is of course worth noting that in setting up the vaccine program the government indemnified vaccine manufacturers, which gave them total cover against all future claims of the adverse effects of their products. Given what I've already explained about the incidence of serious side effects, that cost may well be extremely significant to the taxpayer on top of the obvious human tragedy and loss, which is self-evidently happening.

0:14:25.7 Bridgen: The data is clear, for all healthy people and all those considered at risk under 70, the probability of being seriously harmed by COVID are seriously outweighed by the risk associated from the experimental vaccines and boosters. Even for the most vulnerable group, the over 70s with health problems, the risks are absolutely identical. The government data comments not only on the efficacy and effectiveness of the Autumn booster campaign, which I've quoted from, we've already had that. But it also looks forward to this year's booster campaign, not unsurprisingly it predicts the same level of efficacy from the same boosters put into the same arms. Surely in light of the data, that we are not gonna continue with this absolute madness. Mr. Deputy Speaker, if we were to perpetuate this, what we'll actually be doing is engaging in very expensive state sponsored self-harm on a national level.

0:15:24.6 Bridgen: Mr. Deputy Speaker, in the winter of 2020, the experimental mRNA vaccines were announced to the British public as being safe and effective. That narrative was repeated by the vaccine minister in a response to my speech in this place on the 13th of December. It is interesting that today the NHS website describes the experimental vaccines as safe and important and it describes serious side effects as being very rare. But the truth as we know is somewhat different, one in 800 is not rare, especially when the public is expected to take multiple doses exposing themselves again and again to the same risk. Mr. Deputy Speaker, the government needs to be honest about this, just like they need to be honest about the fact that the MHRA is funded 86% by big pharma. The experimental mRNA vaccines from the manufacturers' own trial data are not safe, with an average of one in 800 people taking or facing death or serious injury as a result. Despite the initial and repeated assurances, the experimental mRNA vaccines from the government's own data that they're not effective at preventing infection, transmission or hospitalization from COVID-19.

0:16:39.7 Bridgen: The experimental mRNA vaccines are not necessary given the risk benefit of the treatment, and the experimental mRNA vaccines are costing the country a fortune and creating huge pressure on the NHS from the side effects. I would therefore ask the minister, given that the data released on the 25th of January by the UK Health Security Agency was actually presented to the JCVI on the 25th of October, 2022, why was the booster rollout not halted last October given the clear lack of efficacy and the evidence of risks being greater than the benefit to all age groups, except possibly the over 70s with underlying health conditions where the risk was absolutely identical?
Was the data presented to the JCVI passed to the the MHRA?

  • If so, when?
  • And if not, why not?

Why were the MHRA still asking the government to authorize the experimental vaccines to be administered to children down to the age of six months of age in December 2022, six weeks after the booster efficacy data was received by the JCVI? If the data was not passed to the MHRA, the Medicines and Healthcare Product Regulatory Agency, surely the JCVI should have spoken out against the vaccination of small children last December.

0:18:00.2 Bridgen: I'm sure Mr. Deputy Speaker that despite the members of the JCVI having declared an interest of over £1 billion between them of investments in big pharma, this would never have influenced their judgment. Can the minister also confirm the fact that two-thirds of NHS staff refused last Autumn's booster? The simple facts are that in light of the government's own data, COVID vaccinations and boosters are not effective. And from the evidence of the Yellow Card system, they're not safe and to the UK taxpayer they're not value for money. Indeed given the side effects, Mr. Deputy Speaker, if they were free, we couldn't afford them, the only ones who'd really benefit from the booster are all the big pharma. With their license to print money and indemnification against the harms of their product scores, once again Mr. Deputy Speaker, big pharma have put profits before people and on this occasion, governments across the globe have been their willing marketing agents. The whole COVID-19 narrative is slowly unraveling, as I believe I've demonstrated today Mr. Deputy Speaker, no one should have been boosted after the efficacy data was received on the 25th of October last year and no one should be boosted in future based on that data.

0:19:13.7 Bridgen: Given the evidence of harms by the boosters I now believe that we have the full explanation of both the continuing excess deaths we've seen since the pandemic, 63,000 excess deaths in England and Wales in the last 12 months. And also the reason for the huge and unrelenting pressure of demand on the NHS. Mr. Deputy Speaker, it's the vaccines and the boosters and their side effects. Sadly, I am confident that I'll be proved correct, I sincerely wish it was not so, but the longer it takes for our government to accept the truth, then more people will be harmed and die. The first step to putting right a problem is always to admit there is a problem, the government narrative of safe and effective is in taters as evidenced by their own data. Three months on from my original speech in this house, we have surely now sacrificed enough of our citizens on the altar of ignorance and unfettered corporate greed to satisfy anyone. I therefore call on the government to immediately stop the mRNA Vaccine Booster Program and initiate a full public inquiry into not only the vaccine harms, but how every agency and institution set up to protect the public interest have failed so abysmally in their duties.

0:20:29.8 Bridgen: I look forward to the minister's response, I'm aware that it's neither his area of responsibility or expertise and I will accept that any questions he can't answer at the dispatch box today that he will send to me in writing.

0:20:42.7 DS: Minister Will Quince.

0:20:43.8 Quince: Well, thank you Mr. Deputy Speaker, and as the honorable gentleman says, I'm responding to the debate on behalf of the Honorable member for Lewes. Vaccines have underpinned the government's strategy for living with COVID-19, they have saved tens of thousands of lives, reduced the pressure on our NHS and were instrumental in allowing our economy and society to reopen. COVID-19 has not gone away and thousands of people in the United Kingdom continue to be infected each week. Vaccines remain our best line of defense and the most effective way to enable us to live with the virus. Countless studies have shown that vaccinated people are less likely to die or become seriously ill from the virus. And thanks to the huge efforts of NHS staff and of course the public, as of the 5th of March, over 144 million vaccine doses have been provided in England alone. This includes over 17 million in the recent Autumn booster campaign, which concluded last month. Now, the honorable gentleman specifically referred to the efficacy of the mRNA COVID-19 boosters, and it's important Mr. Deputy Speaker to put on record that all of the vaccines used in the UK COVID-19 vaccination program have been through a rigorous approval process.

0:21:55.9 Quince: The UK has some of the highest safety standards in the world and the independent medicines and healthcare products regulatory agency, the MHRA, is globally recognized for requiring high standards of quality, safety and effectiveness. And the mRNA COVID-19 boosters approved for use in the United Kingdom have also been through similar rigorous approval processes by the EMA in Europe and the FDA in the United States. And each potential COVID-19 vaccine is assessed by teams of scientists and clinicians on a case by case basis. There are extensive checks and balances required by law at every stage of vaccine development, and it is only once each potential vaccine has met robust standards of quality, safety, and efficacy set by the MHRA that it will be approved for use. Now, both the mRNA and non-mRNA vaccines have already been administered as booster doses with the majority of doses administered in the recent Autumn booster being mRNA vaccines. And data shows that COVID-19 boosters have been highly effective in reducing hospitalizations and death with the mortality rate consistently lower for people who have had at least a third dose or booster dose compared with individuals who are unvaccinated or received just a first or second dose.

0:23:15.2 Quince: Earlier this month, Mr. Deputy Speaker, the Office for National Statistics published their latest COVID-19 effectiveness estimates. They showed between March 21 and March 22, a third booster dose was approximately 93% effective in reducing the risk of mortality from COVID-19 compared to 58% for a first dose and 88% for a second dose. And 77% effective in reducing the risk of hospitalization compared to 52% for a first dose and 55% for the second dose. This highlights the effectiveness of all COVID-19 vaccinations and shows that protection only increases following a third dose or booster as supported by other extensive research such as the UKHSA surveillance reports. And the most recent data from UKHSA on the Autumn 22 booster campaign showed that the mRNA bivalent boosters provided incremental protection against hospitalizations on top of the protection already provided by previous doses in the period following the 5th of September '22. It also showed that the effectiveness against hospitalization remained high at 10 or more weeks after vaccination, which was vital in supporting the NHS over a particularly challenging winter period.

0:24:34.7 Quince: Now, the honorable gentleman also raised the ongoing vaccine surveillance and the surveillance of vaccines does not stop at the point of approval. The MHRA and the UK Health Security Agency continuously monitor a wide range of data regarding the safety and effectiveness of the vaccines, including reports as the honorable gentleman pointed out of adverse reactions from the UK and internationally. And as part of this surveillance, the MHRA's monitoring role includes reviewing all suspected adverse drug reaction reports known as Yellow Card reports relating to COVID-19 vaccines. And through that MHRA Yellow Card scheme, members of the public and healthcare professionals are able to report any suspected side effects, and the nature of Yellow Card reporting means that reported events are not always proven side effects. Some events may have happened anyway regardless of vaccination. Now this comprehensive surveillance strategy alerts us to any unforeseen adverse reactions to the vaccines and enables us to act swiftly when required. Now, Mr. Deputy Speaker, the government is also committed to further research into COVID vaccines, and since the start of the pandemic the National Institute for Health Research, the NIHR has allocated more than £110 million in funding for COVID-19 vaccine research.

0:25:52.5 Quince: And that has included consideration of vaccine safety, including robust monitoring of adverse reactions to COVID-19 vaccines. So in summary, Mr. Deputy Speaker, we know that the COVID vaccination program has saved tens of thousands of lives and has prevented many more from being hospitalized. The government has recently announced that a targeted seasonal vaccination offer will come in in England on the 17th of April, which will top up the protection of those at the highest risk. Vaccination of residents in older adult care homes will start ahead of this from Monday, the 3rd of April. And the primary aim, Mr. Deputy Speaker, of the Spring program continues to be the prevention of severe disease, hospitalizations, and of course death. And older persons, residents in care homes for older adults and those who are immunosuppressed continue to be at highest risk of severe COVID-19 and therefore prioritized for vaccination. Mr. Deputy Speaker, the COVID vaccine program is something of which this country can be very proud, and I would like to reiterate my thanks to the scientists, clinical staff, volunteers, and others who helped to make this happen.

0:27:04.4 DS: Question is for this house to now adjourn. As many of that opinion say aye.

0:27:07.8 S?: Aye.

0:27:08.0 DS: Contrary no, the ayes have it.


Some reporting on Andrew Bridgen


Positive Review of MP points - TrialSite News - March 19

Outcast British MP—1 in 800 COVID-19 Jabs Leads to SAE—‘Absolute Madness’ or Yet Another Subjective Inaccurate Interpretation?

Increasingly an outcast, marginalized and angry, on March 17, British politician Conservative Party MP Andrew Bridgen raised the stakes involving COVID-19 vaccine messaging, presenting a series of claims based on his interpretation of the COVID-19 vaccination data, implying that the UK cannot afford what he deems a very profitable experiment any longer. It was a surreal event given the entire House of Parliament found an anecdote for Bridgend’s anti-COVID vaccine elixir—they simply vacated the premises just as the MP for Northwest Leicestershire and prominent BREXIT supporter stepped up to present. 

But Bridgen continued on, despite a nearly empty hall, presenting what can only be described as an emerging dystopian reality in England and beyond. Overall, the departure represents such a strange state of affairs given the dire message he had for his colleagues, assuming of course the veracity and accuracy of his claims. It’s as if Bridgen himself was a carrier of the most dangerous of infectious diseases.

What was his message? Bridgen and his team analyzed the most recent data from the British government via the UK Health Security Agencythe Yellow Card reporting system and other data from the United States, including Florida’s (which are challenged by U.S. federal health representatives) to present what the MP believes is an incredibly dire situation linked to the COVID-19 mass vaccination response.

An unfolding dystopian program that perpetuates unprecedented “very expensive state-sponsored self-harm on a national level” leading to what Bridgen refers to as “absolute madness.” The MP confidently assures the few bodies in the building that we know what’s behind the excess death rates observed across many nations.

Looking at the government’s data, Bridgen points out that the COVID-19 vaccines are neither safe nor effective. In fact, the MP argues that the data, when considered in the aggregate, points to a dangerous, and anything but rare situation: 1 in 800 people that receive the COVID-19 vaccine or booster will experience a serious adverse event defined by either death, hospitalization or other serious harm—see the link to the U.S. Food and Drug Administration (FDA) for examples.  One in 800 adverse events most certainly isn’t rare and given the challenging efficacy and costs associated with the ongoing mass vaccination program, the MP argues it’s time to conclude this experiment.

What are some of Bridgen’s allegations?
During his presentation, the MP presented a series of numbers he claimed were from the government’s own data revealing not only high numbers of serious adverse events, but also the high costs to prevent just one COVID-19 infection or hospitalization in various age cohorts. 

His speech can be watched on the YouTube channel of John Campbell. A retired nurse teacher, Campbell earned his Ph.D. with an emphasis on nurse education both domestically and abroad. Campbell, a YouTuber since 2007, has developed a sizable following questioning COVID-19 narratives, always done passively and indirectly, so as to not trip YouTube censorship algorithms as the retired nurse also can monetize his audience.

Summary of what many will consider outlandish claims

Designed from the start to promote centralization of medicine and authority while bolstering pharmaceutical industry profits and technological prowess, The COVID-19 vaccination program now enriches biopharmaceutical companies and their investors and ecosystem of stakeholders which includes regulators, according to the MP.   

While the industry has been fully indemnified against any legal actions during the COVID-19 crisis, the profits accumulate to the Pharma companies while any actual benefits of the jabs all but dissipate across the entire population except for the vulnerable elderly, where the COVID-19 vaccination at this stage represents the swapping of one risk for the exact same risk. Hence, profits are captured by industry while the safety implications and costs associated with the national British program are externalized to the public.

At this point, according to the MP, any true efficacy is long gone according to his interpretation of the data. For example, the Conservative MP listed off performance data by age cohort based on January 25, 2023, data from the UK Health Security Agency segmented by age and then by healthy status and risk.  

Claim: 92,500 boosters (to age 40-49) to prevent a COVID hospitalization would create 116 adverse events

It turns out the MP's calculations are correct. The number of booster doses needed to be administered to prevent a single hospitalization or a serious hospitalization (oxygen, etc.) is indeed stark. So, for example, 92,500 boosters must be administered to prevent just one hospitalization of persons in the age 40-49 cohort.

If his serious adverse event numbers are correct, there will be 116 vaccine-induced serious adverse events associated experienced by this cohort.  

Systematic regulatory capture is most certainly a factor suggests Bridgen, given over 70% of the British regulator Medicines and Healthcare Products Regulatory Agency (MHRA) budget is derived from industry according to the MP.

What about the UK’s Joint Committee on Vaccination and Immunization (JCVI)? Well, according to the MP’s analysis, over a billion worth of investment in the Pharma industry is collectively held by members. Are these claims true? TrialSite has assigned a team to substantiate.

What about the bad safety numbers reported in the latest batch of UK Health Security Agency vaccination data? Again, Bridgen’s claims need to be independently verified by multiple competent sources.

That 1 in 800 persons receiving a COVID-19 vaccine or booster would experience a severe adverse event is a shocking revelation if true. This is especially concerning given the move by government authorities, ones that Bridgen claims have become effective pharmaceutical marketing agencies will recommend a jab every year.

The MP concluded that based on the government’s own data (or his interpretation which again could be incorrect—it needs verification) the costs of administering the vaccines (in the billions of pounds) coupled with the risks of adverse events and the general lack of efficacy lead to an “absolute madness” scenario.  MP believes the entire COVID-19 narrative is “slowly unraveling.”

Is Bridgen a noble fighter for the masses or has he become yet another subjective interest in what’s unfolded into a series of profound societal bifurcations, growing chasms across various interests and stakeholders including the swelling anti-vaccination movement now labeled as the cause for medical freedom?

Despite the mass of MPS clearing the building before he could utter a word, Bridgen likely attracts ever more attention and ire. Undoubtedly under a collective magnifying glass myriad interests likely comb nearly every activity for any problems. One surfaced just recently, leading to a five-day suspension at the start of the year.

As reported by The Guardian, Bridgen’s dealings with a constituent got him in hot water. While he claims the 5000-pound payment from a timber company owner seeking benefits in Ghana and the UK was nothing more than a standard constituent interest, the action prompted attention from the Commons Select Committee on Standards and a five-day suspension. 

The MPs much thicker political mud associated with being part of the nationalist/populist conservative-leaning movement (a historical trend?) across many developed nations starting about a decade ago, rejecting the neoliberal globalization project, while embracing decoupling programs such as Brexit, which again reflects changing socio-economic and political, and military dynamics around the world.

Call to Action: Watch the British MP’s presentation via the Dr. Joh Campbell YouTube channel. Is the MP’s interpretation of the data accurate? If so, this has profound implications.


206+ Vaccination pages in VitaminDWiki


There have been 1629 visits to this page

Attached files

ID Name Comment Uploaded Size Downloads
19355 Bridgen 2.jpg admin 19 Mar, 2023 22.17 Kb 159
19354 P - after.jpg admin 19 Mar, 2023 92.46 Kb 177
19353 P before.jpg admin 19 Mar, 2023 59.37 Kb 175
19352 MP.jpg admin 19 Mar, 2023 32.81 Kb 176